pillbase.ru

Hympavzi

Active substance: marstacimab

marstacimab

Centralised EU authorisationActive

Marketing holder: Pfizer Europe MA EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • HYMPAVZI
    INJECTION, SOLUTION · MARSTACIMAB 150 mg/mL
    0069-2151
    Pfizer Laboratories Div Pfizer Inc
  • HYMPAVZI
    INJECTION, SOLUTION · MARSTACIMAB 75 mg/.5mL
    0069-0775
    Pfizer Laboratories Div Pfizer Inc
  • HYMPAVZI
    INJECTION, SOLUTION · MARSTACIMAB 150 mg/mL
    0069-1510
    Pfizer Laboratories Div Pfizer Inc
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-f579-72ac-8f4c-dcaf8bb78847,01a12091-47f1-70b3-874d-39a1a79657d6,01a12095-59e8-7bb9-9df0-9f0154ebf66a;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006240
Registration status
Active
ATC code
B02BX11
Sources
  • product · EMA · EMEA/H/C/006240 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006240 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006240 · Verified 2026-10-09